Anti-inflammatory drugs reduce inflammation and pain. They are commonly used to treat arthritis, injury, infection, or other causes of pain, swelling and fever. Advantages of anti-inflammatory drugs include relief from pain, fever and stiffness. The rising geriatric population base and increasing prevalence of arthritis increases the demand for anti-inflammatory drugs.

The global Anti-Inflammatory Drugs Market is estimated to be valued at US$ 92 Billion in 2023 and is expected to exhibit a CAGR of 5.5% over the forecast period 2023, as highlighted in a new report published by Coherent Market Insights.

Market key trends:
The increasing geriatric population base is one of the major trends driving the growth of the anti-inflammatory drugs market. As per the UN estimates, the global geriatric population, aged 65 years or older, is projected to reach nearly 1.5 billion in 2050 from 703 million in 2019. Elderly people are more susceptible to chronic diseases such as arthritis which increases the demand for anti-inflammatory drugs. Moreover, arthritis is also prevalent in other age groups adding to the demand. According to Arthritis Foundation, around 54 million adults and 0.3 million children have been diagnosed with arthritis in the US. Thus, the growing prevalence of arthritis due to aging population as well as other factors is estimated to propel the demand for anti-inflammatory drugs over the forecast period.

SWOT Analysis
Strength: Anti-inflammatory drugs are effective in treating various inflammatory conditions such as arthritis, tendinitis and others. They help reduce swelling, pain and stiffness.
Weakness: Long term usage of anti-inflammatory drugs can cause side effects like gastric ulcer, kidney problems etc. Overdose may also lead to serious health issues.
Opportunity: Rising ageing population and increasing prevalence of lifestyle diseases resulting in inflammation provides scope for growth of anti-inflammatory drugs market. Growth in healthcare industry in emerging countries also offers opportunities.
Threats: Availability of alternative treatment options like physiotherapy poses competition threat to anti-inflammatory drugs market. Strict regulatory norms for approval of new drugs also act as a challenge.

Key Takeaways

The global anti-inflammatory drugs market is expected to witness high growth.

Regional analysis: Asia Pacific region is expected to be the fastest growing market for anti-inflammatory drugs. Increasing healthcare spending, rising geriatric population, growing prevalence of chronic diseases in countries like India and China are driving the demand in the region.

Key players operating in the anti-inflammatory drugs market are Pfizer, GSK, Novartis, Merck, Eli Lilly and Johnson & Johnson. Pfizer's anti-inflammatory drug Celebrex and Advil from GSK are some of the top-selling brands. Companies are investing in R&D to develop new molecules with reduced side effects to gain competitive edge. Partnerships and licensing agreements are also common in this market.

For More details on the topic:

https://www.rapidwebwire.com/anti-inflammatory-drugs-market-poised-to-experience-high-growth-due-to-rising-prevalence-of-inflammatory-diseases/